BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 24050928)

  • 21. Aggressive pituitary adenomas occurring in young patients in a large Polynesian kindred with a germline R271W mutation in the AIP gene.
    Jennings JE; Georgitsi M; Holdaway I; Daly AF; Tichomirowa M; Beckers A; Aaltonen LA; Karhu A; Cameron FJ
    Eur J Endocrinol; 2009 Nov; 161(5):799-804. PubMed ID: 19684062
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low frequency of AIP mutations in patients with young-onset sporadic pituitary macroadenomas.
    Gaspar LM; Gonçalves CI; Saraiva C; Cortez L; Amaral C; Nobre E; Lemos MC
    J Endocrinol Invest; 2023 Nov; 46(11):2299-2307. PubMed ID: 37149543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel truncating AIP mutation, p.W279*, in a familial isolated pituitary adenoma (FIPA) kindred.
    Cansu GB; Taşkıran B; Trivellin G; Faucz FR; Stratakis CA
    Hormones (Athens); 2016 Jul; 15(3):441-444. PubMed ID: 27838609
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High prevalence of AIP gene mutations following focused screening in young patients with sporadic pituitary macroadenomas.
    Tichomirowa MA; Barlier A; Daly AF; Jaffrain-Rea ML; Ronchi C; Yaneva M; Urban JD; Petrossians P; Elenkova A; Tabarin A; Desailloud R; Maiter D; Schürmeyer T; Cozzi R; Theodoropoulou M; Sievers C; Bernabeu I; Naves LA; Chabre O; Montañana CF; Hana V; Halaby G; Delemer B; Aizpún JI; Sonnet E; Longás AF; Hagelstein MT; Caron P; Stalla GK; Bours V; Zacharieva S; Spada A; Brue T; Beckers A
    Eur J Endocrinol; 2011 Oct; 165(4):509-15. PubMed ID: 21753072
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low rate of germline AIP mutations in patients with apparently sporadic pituitary adenomas before the age of 40: a single-centre adult cohort.
    Preda V; Korbonits M; Cudlip S; Karavitaki N; Grossman AB
    Eur J Endocrinol; 2014 Nov; 171(5):659-66. PubMed ID: 25184284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of aryl hydrocarbon receptor interacting protein (AIP) mutations in familial isolated pituitary adenoma families.
    Igreja S; Chahal HS; King P; Bolger GB; Srirangalingam U; Guasti L; Chapple JP; Trivellin G; Gueorguiev M; Guegan K; Stals K; Khoo B; Kumar AV; Ellard S; Grossman AB; Korbonits M;
    Hum Mutat; 2010 Aug; 31(8):950-60. PubMed ID: 20506337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Germline inactivating mutations of the aryl hydrocarbon receptor-interacting protein gene in a large cohort of sporadic acromegaly: mutations are found in a subset of young patients with macroadenomas.
    Cazabat L; Libè R; Perlemoine K; René-Corail F; Burnichon N; Gimenez-Roqueplo AP; Dupasquier-Fediaevsky L; Bertagna X; Clauser E; Chanson P; Bertherat J; Raffin-Sanson ML
    Eur J Endocrinol; 2007 Jul; 157(1):1-8. PubMed ID: 17609395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Large genomic deletions in AIP in pituitary adenoma predisposition.
    Georgitsi M; Heliövaara E; Paschke R; Kumar AV; Tischkowitz M; Vierimaa O; Salmela P; Sane T; De Menis E; Cannavò S; Gündogdu S; Lucassen A; Izatt L; Aylwin S; Bano G; Hodgson S; Koch CA; Karhu A; Aaltonen LA
    J Clin Endocrinol Metab; 2008 Oct; 93(10):4146-51. PubMed ID: 18628514
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The clinical, pathological, and genetic features of familial isolated pituitary adenomas.
    Beckers A; Daly AF
    Eur J Endocrinol; 2007 Oct; 157(4):371-82. PubMed ID: 17893250
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    Trofimiuk-Müldner M; Domagała B; Sokołowski G; Skalniak A; Hubalewska-Dydejczyk A
    Front Endocrinol (Lausanne); 2023; 14():1098367. PubMed ID: 36843582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutations in the aryl hydrocarbon receptor interacting protein gene are not highly prevalent among subjects with sporadic pituitary adenomas.
    Barlier A; Vanbellinghen JF; Daly AF; Silvy M; Jaffrain-Rea ML; Trouillas J; Tamagno G; Cazabat L; Bours V; Brue T; Enjalbert A; Beckers A
    J Clin Endocrinol Metab; 2007 May; 92(5):1952-5. PubMed ID: 17299063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. AIP mutations and gigantism.
    Rostomyan L; Potorac I; Beckers P; Daly AF; Beckers A
    Ann Endocrinol (Paris); 2017 Jun; 78(2):123-130. PubMed ID: 28483363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequency of familial pituitary adenoma syndromes among patients with functioning pituitary adenomas in a reference outpatient clinic.
    Marques NV; Kasuki L; Coelho MC; Lima CHA; Wildemberg LE; Gadelha MR
    J Endocrinol Invest; 2017 Dec; 40(12):1381-1387. PubMed ID: 28689311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [AIP mutations in familial and sporadic pituitary adenomas: local experience and review of the literature].
    Fajardo-Montañana C; Daly AF; Riesgo-Suárez P; Gómez-Vela J; Tichomirowa MA; Camara-Gómez R; Beckers A
    Endocrinol Nutr; 2009; 56(7):369-77. PubMed ID: 19883897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pituitary adenoma predisposition caused by germline mutations in the AIP gene.
    Vierimaa O; Georgitsi M; Lehtonen R; Vahteristo P; Kokko A; Raitila A; Tuppurainen K; Ebeling TM; Salmela PI; Paschke R; Gündogdu S; De Menis E; Mäkinen MJ; Launonen V; Karhu A; Aaltonen LA
    Science; 2006 May; 312(5777):1228-30. PubMed ID: 16728643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical experience in the screening and management of a large kindred with familial isolated pituitary adenoma due to an aryl hydrocarbon receptor interacting protein (AIP) mutation.
    Williams F; Hunter S; Bradley L; Chahal HS; Storr HL; Akker SA; Kumar AV; Orme SM; Evanson J; Abid N; Morrison PJ; Korbonits M; Atkinson AB
    J Clin Endocrinol Metab; 2014 Apr; 99(4):1122-31. PubMed ID: 24423289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aryl hydrocarbon receptor interacting protein (AIP) mutations occur rarely in sporadic parathyroid adenomas.
    Pardi E; Marcocci C; Borsari S; Saponaro F; Torregrossa L; Tancredi M; Raspini B; Basolo F; Cetani F
    J Clin Endocrinol Metab; 2013 Jul; 98(7):2800-10. PubMed ID: 23633209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Familial isolated pituitary adenomas (FIPA) and mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene.
    Daly AF; Beckers A
    Endocrinol Metab Clin North Am; 2015 Mar; 44(1):19-25. PubMed ID: 25732638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Familial acromegaly due to aryl hydrocarbon receptor-interacting protein (AIP) gene mutation in a Turkish cohort.
    Niyazoglu M; Sayitoglu M; Firtina S; Hatipoglu E; Gazioglu N; Kadioglu P
    Pituitary; 2014 Jun; 17(3):220-6. PubMed ID: 23743763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk category system to identify pituitary adenoma patients with
    Caimari F; Hernández-Ramírez LC; Dang MN; Gabrovska P; Iacovazzo D; Stals K; Ellard S; Korbonits M;
    J Med Genet; 2018 Apr; 55(4):254-260. PubMed ID: 29440248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.